Literature DB >> 9383012

Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I.

M Gattu1, J R Pauly, K L Boss, J B Summers, J J Buccafusco.   

Abstract

Both human essential hypertension and genetically induced hypertension in rats have been associated with a range of impairments of cognitive ability. The spontaneous hypertensive rat (SHR) previously has been shown to exhibit a decrease in the expression of brain nicotinic acetylcholine receptors, a factor that could play a role in the impaired ability of this strain in the performance of learning and memory-related tasks. The purpose of this study was to help determine whether task impairment by SHR was related to the reduced expression of central nicotinic acetylcholine receptors. Twelve-week-old SHR were tested in two phases of a water maze (spatial memory) task, and their performance was compared with that of two age-matched normotensive strains, Wistar Kyoto (WKY) and Wistar rats. During Phase 1, SHR exhibited significantly increased latencies to locate a hidden platform as compared with either WKY or Wistar rats. During Phase 2 (subsequent series of trials after a 4-day inter-phase period), where rats were required to find a new platform location, SHR again exhibited significantly impaired performance compared to the normotensive strains. In a single trial passive avoidance paradigm, SHR again displayed significantly reduced avoidance behavior as compared with both WKY and Wistar rats. In consecutive coronal sections, the density of [3H]cytisine binding sites was decreased in SHR by up to 25% in about half of the brain regions examined, with the deficits particularly apparent in cephalic regions. The binding of [125I]alpha-bungarotoxin to brain sections also was decreased in SHR; however, only certain brain areas exhibited significant interstrain differences. These alterations in the expression of putative nicotinic receptor subtypes in SHR were not due to changes in the density of cholinergic neurons since there were no interstrain differences in the binding densities for [3H]vesamicol, which labels the vesicular acetylcholine transporter. Moreover, the magnitude of nicotine-stimulated rubidium efflux from cortical and striatal synaptosomes in vitro was significantly reduced in samples derived from SHR as compared with those from normotensive rats. These results are consistent with the possibility that a reduction in the expression of cortical nicotinic receptors in SHR plays a role in this strain's impaired performance of both spatial and non-spatial learning and memory-related tasks.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9383012     DOI: 10.1016/s0006-8993(97)00793-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

1.  Chronic, severe hypertension does not impair spatial learning and memory in Sprague-Dawley rats.

Authors:  I Kadish; T van Groen; J M Wyss
Journal:  Learn Mem       Date:  2001 Mar-Apr       Impact factor: 2.460

2.  The involvement of central cholinergic system in the pressor effect of intracerebroventricularly injected U-46619, a thromboxane A2 analog, in conscious normotensive rats.

Authors:  Murat Yalcin; Sinan Cavun; M Sertac Yilmaz; Vahide Savci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-26       Impact factor: 3.000

3.  Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD.

Authors:  Mattis B Wigestrand; Yann S Mineur; Christopher J Heath; Frode Fonnum; Marina R Picciotto; Sven Ivar Walaas
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

4.  Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo.

Authors:  Xinyu D Li; Esperanza Arias; Ramamohana R Jonnala; Shyamala Mruthinti; Jerry J Buccafusco
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  Set shifting in a rodent model of attention-deficit/hyperactivity disorder.

Authors:  Amy C Chess; Brittany E Raymond; Ira G Gardner-Morse; Mark R Stefani; John T Green
Journal:  Behav Neurosci       Date:  2011-06       Impact factor: 1.912

Review 6.  Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition.

Authors:  Alvin V Terry; Caterina M Hernandez; Elizabeth J Hohnadel; Kristy P Bouchard; Jerry J Buccafusco
Journal:  CNS Drug Rev       Date:  2005

Review 7.  Attention-modulating effects of cognitive enhancers.

Authors:  Edward D Levin; Philip J Bushnell; Amir H Rezvani
Journal:  Pharmacol Biochem Behav       Date:  2011-02-18       Impact factor: 3.533

8.  Medial temporal lobe functioning and structure in the spontaneously hypertensive rat: comparison with Wistar-Kyoto normotensive and Wistar-Kyoto hypertensive strains.

Authors:  Audrey M Wells; Amy C Janes; Xiaoxu Liu; Christian F Deschepper; Marc J Kaufman; Kathleen M Kantak
Journal:  Hippocampus       Date:  2010-06       Impact factor: 3.899

9.  Nicotine-induced behavioral sensitization in an adult rat model of attention deficit/hyperactivity disorder (ADHD).

Authors:  Elizabeth Watterson; Alexander Spitzer; Lucas R Watterson; Ryan J Brackney; Arturo R Zavala; M Foster Olive; Federico Sanabria
Journal:  Behav Brain Res       Date:  2016-06-27       Impact factor: 3.332

Review 10.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.